• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of analytical package reviews received via FDA's electronic Compliance Management System (CMS) that meet Office of Compliance (OC) timeframes as specified in CMS in the quarter

Dictionary: FDA ensures the safety of regulated products in part by performing laboratory analyses that monitor compliance with its regulations. If foods, dietary supplements or cosmetics are found to contain potentially unsafe contaminants during FDA laboratory analyses then the analytical packages must be reviewed to determine if they support regulatory action. Improving the efficiency of analytical regulatory package reviews will speed enforcement actions and more rapidly ensure the safety of U.S. foods, dietary supplements and cosmetics by removing potentially harmful products from the marketplace.

Information is current as of June 30, 2014.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercentage
Oct-Dec 20109087
Jan-Mar 20119099
Apr-Jun 20119091
Jul-Sep 20119091

FY 2011 Overall: 92%

Number of analytical package reviews received via CMS that meet OC timeframes in the quarter

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct-Dec 2010N/A48
Jan-Mar 2011N/A69
Apr-Jun 2011N/A63
Jul-Sep 2011N/A58

FY 2011 Total: 238

Total number of analytical packages reviewed within CMS in the quarter

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct-Dec 2010N/A55
Jan-Mar 2011N/A70
Apr-Jun 2011N/A69
Jul-Sep 2011N/A64

FY 2011 Total: 258

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.